Last Chance Brilliant Violet 421™ Anti-human Hla-e - Today Only [Wk9sMUbu]

Brilliant Violet 421™ Anti-human HLA-E

The Last Chance Brilliant Violet 421™ Anti-human Hla-e - Today Only [Wk9sMUbu] is a highly specialized monoclonal antibody designed to target the non-classical MHC class I molecule HLA-E. This product offers a unique tool for researchers studying immune regulation and NK cell function. With its robust binding affinity and specificity, it enables detailed analysis of HLA-E expression and interaction with CD94/NKG2 receptors.

Product Specifications

The antibody, clone 3D12, is produced by immunizing mice with human HLA-E. It is formatted in a convenient BV421 conjugation, which provides optimal visualization with flow cytometry. The monoclonal nature of this antibody ensures consistent and reliable results across experiments. Key features include:

Reactivity: Human

Format: BV421

Host: Mouse

Isotype: IgG1, κ

For added convenience, this product is regulated under RUO status, making it ideal for research applications without clinical use.

Applications and Benefits

The Last Chance Brilliant Violet 421™ Anti-human Hla-e - Today Only [Wk9sMUbu] is a valuable asset for researchers focused on immune system research. It can be used in various applications, such as:

Flow cytometry for assessing HLA-E expression and function

Monitoring NK cell cytolysis activities

By using this antibody, scientists can gain a deeper understanding of immune regulation and the role of HLA-E in the immune response. This product is particularly beneficial for researchers in immunology, oncology, and infectious diseases, where detailed analysis of immune cell interactions is critical.